An alternative hypothesis regarding the development of DMN suggests the existence of hypercoagulability, including antithrombin II deficiency, elevated levels of factor VII, hyperhomocysteinemia, the presence of antiphospholipid antibodies, and reduced levels of both prostacyclin and tissue plasminogen activator. The gene discussed is F7; the disease is thrombophilia.